Rienk Offringa

7PUBLICATIONS
33CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersBiologically active moleculesMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 10, 2026
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire.

Hannes Kehm, Stefan Zens, Daniel Baumann

|Jun 03, 2025
Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer.

|Sep 27, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer.

Jeffrey Mowat, Rafael Carretero, Gabriele Leder

|Nov 15, 2023
Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer.

Zibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan

|Aug 18, 2022
The expanding role for small molecules in immuno-oncology.

Rienk Offringa, Lisa Kötzner, Bayard Huck

|Jul 21, 2021
p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition.

Daniel Baumann, Jennifer Drebant, Tanja Hägele

Pageof 2

Frequent Collaborators

4 joint publications

Isabel Poschke

3 joint publications

Michael Volkmar

2 joint publications

Angelika B Riemer

2 joint publications

Jonas D Förster